Cambrium's mission is to trigger the next wave of material innovation by harnessing nature’s protein building blocks. We fundamentally believe that the ability to align economic and environmental incentives makes biology the most important manufacturing technology of the 21st century.
We are accelerating a Cambrian explosion of biomaterials to address the world’s most pressing problems. Our platform combines protein engineering, machine learning and lab automation to create high-performance materials at scale.
We are accelerating a Cambrian explosion of biomaterials to address the world’s most pressing problems. Our platform combines protein engineering, machine learning and lab automation to create high-performance materials at scale.
Location: Germany, Berlin
Employees: 11-50
Total raised: $8.46M
Founded date: 2020
Investors 1
| Date | Name | Website |
| - | Merantix C... | merantix-c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.10.2023 | Seed | $8.46M | - |
Mentions in press and media 7
| Date | Title | Description |
| 12.01.2025 | The Rise of Vegan Innovations: A New Era in Beauty and Food | In a world increasingly aware of its ecological footprint, two companies are leading the charge toward sustainable alternatives in beauty and food. Brenntag and Cambrium are redefining skincare with vegan collagen, while Bon Vivant is trans... |
| 10.01.2025 | Brenntag Partners With Cambrium to Launch Skin-Identical Vegan Collagen in Key European Markets | Global chemicals and ingredients distributor Brenntag has partnered with biotechnology company Cambrium to introduce NovaColl, a skin-identical vegan collagen, to the beauty and personal care market in the UK, Ireland, Iberia, France, and I... |
| 31.10.2023 | Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules | - |
| 31.10.2023 | Cambrium Raises €8M in Seed Funding | Cambrium, a Berlin, Germany-based synthetic biology startup, raised €8M in Seed funding. The round was led by Essential Capital, along with SNR, Valor Equity Partners, and HOF Capital. The company intends to use the funds to translate the e... |
| 31.10.2023 | Cambrium aims to one-up nature with designer proteins that scale sustainably | Nature has done a hell of a job over the last few billion years, but there’s always room for improvement. The proteins in our bodies are great but not always the easiest to produce or package — so Cambrium is looking to design improved mole... |
| 24.01.2023 | Ginkgo Bioworks Fires Up Its Bio Foundry To Take On The Billion-Dollar Enzyme Market | Ginkgo Bioworks banner on the façade of the New York Stock Exchange building.Ginkgo Bioworks |
| - | Cambrium | “Cambrium” |